Month: December 2016

Original article published by ETH Zurich on December 1, 2016. Click here to read the original article. Researchers have used the simplest approach yet to produce artificial beta cells from human kidney cells. Like their natural model, the artificial cells act as both sugar sensors and insulin producers. Researchers led by ETH Professor Martin Fussenegger at…

At the Diabetes Research Connection, our passion is working together with the scientific community to find a way to treat, cure and prevent type 1 diabetes, and our board is dedicated to helping achieve our vision. 2016 has been a monumental year for us, as we’ve raised more money than ever before for early-career scientists’…

Original article published by IOP Science on December 1, 2016. Click here to read the original article. Abstract Transplantation of human pluripotent stem cells (hPSC) differentiated into insulin-producing βcells is a regenerative medicine approach being investigated for diabetes cell replacement therapy. This report presents a multifaceted transplantation strategy that combines differentiation into stem cell-derived β (SC-β)…

The holiday season is in full swing, and many of us will be traveling this month to visit friends, family and loved ones. For those with type 1 diabetes (T1D), though, holiday travels may require a bit more planning. Below we’ve outlined a few things to keep in mind when planning a trip if you…

Original article published by The JAMA Network on October 4, 2016. Click here to read the original article. A new device that automatically monitors blood glucose levels and adjusts insulin levels has received FDA approval. The device, manufactured by Dublin-based Medtronic PLC, is the first such system to gain the agency’s blessing. The new MiniMed 670G…